Back to calendar
Rein Therapeutics, Inc. (RNTX) Earnings
RNTX reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.27
Actual EPS: $-0.19
EPS surprise: 61.22%
Company overview
Market Cap$76.5M
PriceUSD 0.89
EPS (TTM)-1.91
52-week high2.18
52-week low0.83
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees10